A detailed history of Bridgeway Capital Management, LLC transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 108,900 shares of AIM stock, worth $49,005. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108,900
Previous 108,900 -0.0%
Holding current value
$49,005
Previous $47,000 8.51%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.32 - $0.77 $13,472 - $32,417
-42,100 Reduced 27.88%
108,900 $46,000
Q2 2022

Aug 15, 2022

SELL
$0.78 - $1.27 $7,800 - $12,700
-10,000 Reduced 6.21%
151,000 $118,000
Q1 2022

May 16, 2022

SELL
$0.67 - $1.18 $36,850 - $64,900
-55,000 Reduced 25.46%
161,000 $171,000
Q4 2021

Feb 14, 2022

SELL
$0.92 - $1.96 $18,400 - $39,200
-20,000 Reduced 8.47%
216,000 $199,000
Q3 2021

Nov 15, 2021

SELL
$1.91 - $2.17 $19,100 - $21,700
-10,000 Reduced 4.07%
236,000 $477,000
Q2 2021

Aug 16, 2021

SELL
$1.93 - $2.39 $48,250 - $59,750
-25,000 Reduced 9.23%
246,000 $529,000
Q1 2021

May 17, 2021

BUY
$1.88 - $2.82 $300,800 - $451,200
160,000 Added 144.14%
271,000 $615,000
Q4 2020

Feb 16, 2021

BUY
$1.68 - $2.45 $186,480 - $271,950
111,000 New
111,000 $199,000

Others Institutions Holding AIM

About AIM ImmunoTech Inc.


  • Ticker AIM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,049,300
  • Market Cap $21.6M
  • Description
  • AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...
More about AIM
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.